Emilie Grard

Emilie Grard is Health Investment Analyst at MedAccess, supporting the scoping, development, and execution of agreements across a range of health areas.

Emilie is a member of selected agreement teams, working with leads to support the agreement development process and evaluate opportunities to support emerging health products. She is actively involved in rigorously analysing public health impact and conducting due diligence on priority markets, informing how MedAccess structures and shapes its partnerships.

In addition, Emilie plays a key project management role within the Health Investments team in which she oversees the pipeline database and its prioritisation process. This allows the team to track developments across various health products and disease areas.

Emilie is a postgraduate specialising in global health research and development. She completed a Bachelor’s degree in Global Public Health at the University of Virginia, where she developed her knowledge of the global health landscape and pursued an interest in women’s health, maternal health, and sexual and reproductive health.

Afterwards, Emilie undertook a Master of Public Health at Imperial College, London. Maintaining her interest in sexual and reproductive health, she focused her dissertation on the evaluation of the availability and quality of emergency obstetric care in sub-Saharan Africa. She was also part of an HIV research project in partnership with UNAIDS, which focused on at-risk populations across sub-Saharan Africa and the accessibility of HIV testing and treatment.

Whilst pursuing her bachelor’s degree, Emilie was part of a virtual research project in partnership with the University for Global Health Equity in Rwanda. She collaborated with medical students from Rwanda to evaluate the barriers hindering access to reproductive healthcare in rural communities.